LRRC34P1

Across TCGA pan-cancer cohorts, LRRC34P1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LRRC34P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LRRC34P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LRRC34P1 expression acts as an unfavorable survival marker.

ACC, KIRC, and BLCA are the cancer types where LRRC34P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.139	0.812	<.001	171	view →
KIRC	OS	Tertile	All	0.519	0.659	<.001	162	view →
BLCA	DFS	Tertile	III,IV	0.193	0.506	.004	36	view →
STAD	DFS	Quartile	III,IV	0.328	0.655	.011	30	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	27	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
LGG	OS	Tertile	All	0.748	0.915	.006	12	view →
SKCM	OS	Tertile	IV	0.226	0.613	.034	9	view →
GBM	OS	Tertile	All	0.153	0.420	.024	9	view →
MESO	OS	Tertile	II,III,IV	0.180	0.560	.046	9	view →
LIHC	DFS	Tertile	All	0.140	0.533	.004	9	view →
KIRP	OS	Tertile	All	0.323	0.717	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LRRC34P1–ACC (OS)

Open the ACC breakdown →